CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Hemcheck Sweden AB Company Snapshot
Hemcheck Sweden AB operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hemcheck Sweden AB with three other pharmaceutical manufacturers in Europe: Kancera AB (2020 sales of 90,000.00 Swedish Kronor [US$10,430.10 ] ), StenoCare A/S (277,780.14 Swedish Kronor [US$32,191.94 ] ), and Index Pharmaceuticals Holding Ab (35,000.00 Swedish Kronor [US$4,056.15 ] ).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Hemcheck Sweden AB
  Stock Performance Chart for Hemcheck Sweden AB
 
  Stock Data: Recent Stock Performance:
  Current Price (4/1/2021): 3.33
(Figures in Swedish Kronor)
1 Week 2.1%   13 Weeks -7.2%  
4 Weeks -29.3%   52 Weeks -12.1%  
 
Hemcheck Sweden AB Key Data:
  Ticker: HEMC Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2020 Sales 306,810
(Year Ending Jan 2021).
Employees: N/A
  Currency: Swedish Kronor Market Cap: 52,308,406
  Fiscal Yr Ends: December Shares Outstanding: 15,708,230
  Share Type: Aktie Closely Held Shares: N/A
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.